ArticleCureus2025
Changes in Plasma Glycine Concentration in General Anesthesia With Remifentanil: A Prospective Observational Pilot Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRemifentanil-based anesthesia has been associated with postanesthetic shivering (PAS) and postoperative pain consistent with opioid-induced hyperalgesia (OIH). PAS and OIH have been suggested to involve N-methyl-D-aspartate (NMDA) receptor signaling. Glycine participating in the NMDA receptor functions as a co-agonist. Commercial remifentanil formulations contain glycine as an excipient, raising the question of whether perioperative exposure to this medication increases circulating glycine levels, potentially including those in the central nervous system.
objectiveThe objective of this study is to confirm the elevation of plasma glycine and its perioperative course during general anesthesia with glycine-containing remifentanil.
methodsAn open-label, single-center, preliminary prospective observational study was performed in adults undergoing elective pancreaticoduodenectomy. Patients with renal dysfunction or liver dysfunction were excluded. Balanced anesthesia included desflurane, propofol, remifentanil (Ultiva; 7.5 mg glycine per 1 mg remifentanil) infused at 0-0.2 μg/kg/min, fentanyl, and rocuronium. No glycine-containing IV fluids were administered. Plasma glycine was quantified by enzyme-linked immunosorbent assay at six time points: pre-induction (T0), 120 min after induction (T1), end of remifentanil (T2), and one hour (T3), two hours (T4), and three hours (T5) after completion. PAS, Face Pain Scale-revised (FPS-R), ICU Confusion Assessment Method (CAM-ICU), and ionized magnesium on ICU admission were recorded exploratorily. Changes over time were assessed using a repeated-measures ANOVA with the Greenhouse-Geisser correction and Dunnett comparisons versus T0 (α = 0.05).
resultsTwelve patients were enrolled, and 10 participants completed the protocol. Plasma glycine ranged from 200 to 500 μmol/L. There was no significant increase at any remifentanil infusion rate. Compared with pre-induction, plasma glycine levels were significantly lower at two hours (T4) and three hours (T5) post-remifentanil (p < 0.05). One patient exceeded the reference range for glycine despite preservation of hepatic and renal function. The study was not powered to test associations with PAS or OIH.
conclusionsIn surgical patients with preserved organ function, anesthesia with glycine-containing remifentanil did not elevate plasma glycine levels in 9 of 10 cases, limiting evaluation of an NMDA receptor-mediated mechanism. Further investigation should consider evaluating plasma concentrations when high-concentration remifentanil or glycine-containing formulations are used concomitantly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.